Midi Health Cost 2026: Tirzepatide, GLP-1, and HRT Pricing

Does Midi Health offer tirzepatide, and what does GLP-1 actually cost there?

If you landed here searching something like midi health tirzepatide cost, the direct answer is that Midi's storefront doesn't sell a product labeled tirzepatide. That's an easy assumption to make — Zepbound and Mounjaro dominate the GLP-1 conversation right now — but Midi lists something else on its pricing page: a compounded option it calls a dual-action GLP-1/GIP, in both injectable and sublingual (oral) form.

That naming isn't a dodge so much as a compounding-pharmacy convention. Tirzepatide's mechanism is dual-action — it activates both the GLP-1 and GIP receptors, unlike semaglutide, which only activates GLP-1. The dose tiers Midi lists for its dual-action product track the same escalation pattern used for tirzepatide therapy. In practical terms, a woman asking about tirzepatide at Midi is looking at this compounded dual-action listing, not a separate, differently priced item.

Midi actually runs two separate GLP-1 products, worth naming side by side so the numbers below don't read as contradictory: a single-mechanism semaglutide-equivalent starting around $165.90/mo, and the dual-action GLP-1/GIP (tirzepatide-equivalent) starting around $210/mo. They're different products at different price points, not two prices for the same thing.

• Dual-action GLP-1/GIP injectable: from about $210/mo at the starting dose, rising to roughly $434/mo at the highest maintenance tier
• Dual-action GLP-1/GIP sublingual (oral): from about $209/mo at the starting dose, rising to roughly $460/mo at the highest tier
• No separate membership fee — shipping and supplies are built into the price shown
• Compounded through Midi's partner pharmacies, described on its own pricing page as 503B-accredited

There's a second, separate path worth knowing about: Midi's own materials state that clinicians can also prescribe brand-name GLP-1s — think Zepbound, Mounjaro, Wegovy, or Ozempic — sent to a pharmacy of your choice. That route isn't priced on Midi's site at all, because the cost depends entirely on your insurance formulary and pharmacy benefit rather than anything Midi controls. If a branded prescription is what you actually want, ask about it directly during intake rather than assuming the compounded listing is your only option.

How much does Midi Health cost with insurance?

Insurance is where Midi's hormone therapy business genuinely differentiates itself. The platform is in-network with most PPO plans, and Midi's own materials put that figure at roughly 80% of PPO plans nationally. For a qualifying patient, that means a specialist menopause visit costs whatever your plan's standard copay is — commonly cited as landing somewhere between $0 and $30-plus, with an average out-of-pocket cost around $50 per visit once deductibles and coinsurance are factored in.

• In-network PPO: standard copay applies, commonly $0–$30+ per visit
• Average reported out-of-pocket cost with insurance: around $50 per visit
• HSA/FSA cards can be used toward copays and deductibles
• Medicare, Medicaid, and Medi-Cal are not accepted — those patients pay self-pay rates

The catch is that insurance billing at Midi covers HRT visits, not the compounded GLP-1 program — that track is self-pay regardless of what plan you carry, with the possible exception of a brand-name GLP-1 prescription billed through your own pharmacy benefit rather than through Midi.

What does Midi Health cost without insurance?

If you're on an HMO, uninsured, or Midi is simply out-of-network for your specific plan, self-pay pricing takes over. An initial visit runs $250. Every follow-up after that runs $150. There's no monthly membership charge sitting underneath those numbers — you're paying per visit, not renting access to the platform.

That per-visit structure means your total cost tracks how often you actually need to be seen, not a flat subscription you're locked into whether you use it or not. A patient who needs quarterly follow-ups pays a predictable, bounded amount; someone who needs more frequent dose adjustments early on will naturally pay more in year one than in year two.

Midi Health semaglutide cost — what's included?

Separate from the dual-action tirzepatide-equivalent, Midi also lists a single-mechanism GLP-1 option — the compounded equivalent of semaglutide — in both injectable and sublingual formats. This is the lower-cost entry point into Midi's weight-management track.

• GLP-1 injectable: from about $165.90/mo at the starting dose, rising to roughly $340–$355/mo at the highest tier
• GLP-1 sublingual (oral): from about $164/mo at the starting dose, rising to roughly $275/mo at the highest tier
• Shipping and supplies included — no add-on delivery charge

You may see an older figure floating around — around $128 a month — attached to Midi's GLP-1 program. That number appears to reflect the medication charge alone, before a roughly $38 refrigerated-shipping fee that Midi's current pricing page has since folded directly into the sticker price. The $165.90 starting figure above is the more complete, current all-in number.

What's not included — labs, state availability, and other costs to plan for

Midi's clinicians can order blood work when it's clinically useful — hormone panels for HRT candidates, metabolic markers for GLP-1 patients — typically routed through Labcorp. That's a real service, but it isn't a flat, bundled fee sitting inside your visit price. Whether a given lab costs you nothing or something out of pocket depends on your insurance and the specific panel ordered.

• Labs: ordered as needed, usually via Labcorp, billed through insurance or separately
• State availability: Midi is not available in all 50 states — check the state-selector tool on joymidi.com before you start intake
• Insurance exclusions: Medicare, Medicaid, and Medi-Cal are not accepted on any track
• Regulatory note: Midi's compounded GLP-1 pharmacy partners are described as 503B-accredited, which is the exact facility category named in the FDA's proposed rule to remove semaglutide and tirzepatide from the bulk 503B compounding list — a medium-term supply and pricing risk worth watching rather than an immediate problem

How much does Midi Health cost per year?

The annual math splits cleanly by track, and it depends heavily on how often you're seen and which medication you choose.

• Self-pay HRT (1 initial + 3 follow-ups): $250 + ($150 × 3) = $700/yr
• In-network PPO HRT, four visits at an average $30 copay: roughly $120/yr
• Compounded semaglutide-equivalent GLP-1, starting dose held all year: $165.90 × 12 = about $1,991/yr
• Compounded dual-action GLP-1/GIP (tirzepatide-equivalent), highest tier held all year: $434 × 12 = about $5,208/yr

Most patients land somewhere in between those GLP-1 bookends, since doses typically escalate over the first several months rather than starting at the maintenance tier. A woman combining HRT and the GLP-1 program should expect the GLP-1 medication to dominate her annual spend by a wide margin — the hormone side, especially with insurance, is comparatively inexpensive.

How does Midi's cost compare to Winona, Alloy, and other menopause telehealth?

On HRT specifically, Midi's insurance model changes the comparison entirely. Winona charges a flat $99–$139 a month, cash-pay only, with no insurance option at all. Alloy charges a one-time $49.95 consult plus roughly $75 a month, also cash-pay, positioned around Menopause Society–certified physicians rather than lower price. Both are straightforward, predictable subscriptions. Midi's self-pay rate of $250 initial / $150 follow-up isn't cheaper than either on a pure sticker-price basis — but for the roughly 80% of PPO-insured patients Midi can bill directly, the effective cost drops well below both, often to a standard office-visit copay. For a fuller side-by-side, see Winona vs. Midi Health.

On the GLP-1 side, Midi's compounded pricing is genuinely competitive once you account for how other platforms bill. Henry Meds charges $349/mo for oral tirzepatide and $449/mo injectable, all-in with no membership fee — both above Midi's $210 starting price for its dual-action option, though Midi's price climbs to a comparable $434 at the highest dose tier. Mochi Health charges $278/mo all-in for tirzepatide with no dose-based increase at all, which undercuts Midi at higher doses but not at the entry tier. None of these platforms bill insurance for compounded GLP-1s — that part of the market is cash-pay across the board.

Is Midi Health worth the cost?

For PPO-insured women who came for HRT, Midi's cost case is strong — a specialist-trained menopause visit at a standard copay is a genuinely rare offering in this category, and it's the reason the platform earns its recommendation in the full Midi Health review. For the woman who came specifically expecting a tirzepatide price tag, the honest answer is that Midi's compounded dual-action GLP-1/GIP product covers similar clinical ground, priced from about $210 a month, without using that exact word on the storefront.

Where it's a weaker fit: uninsured or HMO patients who want the lowest possible sticker price on HRT, anyone who wants a bundled lab package rather than case-by-case ordering, and patients who specifically need a branded medication billed at a guaranteed price rather than through their own pharmacy benefit. For everyone else — particularly PPO-insured women who want specialist HRT and are open to a compounded metabolic option alongside it — the math holds up.